Foghorn Therapeutics Inc. (FHTX) Profit Margins
Over the twelve months to 2026-06-30, Foghorn Therapeutics Inc. (FHTX) had operating margin -198.0%, net margin -175.8%, free cash flow margin -229.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FHTXFoghorn Therapeutics Inc.Follow FHTX — free
—
Price chart with a free account
- Market cap
- 118.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | 89.4% | 86.1% | — | |
| Operating margin | -15937.4% | -7637.1% | -609.2% | -315.9% | -454.3% | -279.5% | -198.0% | |
| Net margin | -16000.0% | -7681.6% | -566.3% | -288.2% | -383.2% | -240.3% | -175.8% | |
| FCF margin | -11039.3% | -4060.9% | 1000.6% | -349.4% | -448.2% | -278.7% | -229.4% |
USD millions · SEC XBRL
Foghorn Therapeutics Inc. — questions
- What is Foghorn Therapeutics Inc.'s operating margin?
- -198.0% over the twelve months to 2026-06-30.
- What is Foghorn Therapeutics Inc.'s net profit margin?
- -175.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Foghorn Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.